Yelba M. Castellon-Lopez

Dr. Yelba M. Castellon-Lopez

UCLA Health, Los Angeles, California, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Yelba M. Castellon-LopezYelba M. Castellon-Lopez
Yelba M. Castellon-Lopez
SCSavanna L. Carson
Savanna L. Carson
LMLisa Mansfield
Lisa Mansfield
NGNanibaa’ A. Garrison
Nanibaa’ A. Garrison
JBJuan Barron
Juan Barron
Alejandra CasillasAlejandra Casillas
Alejandra Casillas
Objective. Latino adults in Los Angeles have experienced disproportionate cases, deaths, and socioeconomic impacts from the COVID-19 pandemic. This qualitative study aimed to explore community perspectives on readiness for COVID-19 vaccination and to identify culturally tailored vaccine outreach strategies. Methods. We conducted virtual focus groups with Los Angeles County Latino/a residents via Zoom between December 2020 to January 2021, as the first COVID-19 vaccines were receiving Emergency Use Authorization (EUA). Focus groups were facilitated in Spanish and English by bilingual members of the research team. Discussions were analyzed via Atlas.ti software using reflexive thematic analysis. Results. Three focus groups (n = 15; four to six people each; two Spanish focus groups; one English) were conducted. Thematic findings centered on Latino COVID-19 vaccine equity: (1) Disproportionate infection risk due to essential worker status and socioeconomic burdens, misinformation, and familial or cultural tensions (2) Concerns for inequitable vaccine access due to immigration fears and limited healthcare access, and (3) A need for community-centered COVID-19 vaccine outreach and access. Conclusions. Our study on early Latino adult reactions to vaccine roll-out suggests the need for outreach strategies centering on validating community hardships, combating dis-/misinformation through trusted sources, and addressing socio-economic needs impacted by the pandemic.

6 October 2022 in Journal of Clinical and Translational Science
Verified
Journal Article
Open access
PDF file
Yelba M. Castellon-LopezYelba M. Castellon-Lopez
Yelba M. Castellon-Lopez
RLRaphael Landovitz
Raphael Landovitz
ENEjiro Ntekume
Ejiro Ntekume
CPCourtney Porter
Courtney Porter
RBRachelle Bross
Rachelle Bross
TPThe Los Angeles COVID-19 Vaccine Trials Community Consultant Panel
The Los Angeles COVID-19 Vaccine Trials Community Consultant Panel
Introduction:Communities of color have faced disproportionate morbidity and mortality from COVID-19, coupled with historical underrepresentation in US clinical trials, creating challenges for equitable participation in developing and testing a safe and effective COVID-19 vaccine. Methods:To increase diversity, including racial and ethnic representation, in local Los Angeles County NIH-sponsored Phase 3 SARS-CoV-2 vaccine clinical trials, we used deliberative community engagement approaches to form a Community Consultant Panel (CCP) that partnered with trial research teams. Thirteen members were recruited, including expertise from essential workers, community-based and faith-based organizations, or leaders from racial and ethnic minority communities. Results:Working closely with local investigators for the vaccine studies, the CCP provided critical insight on best practices for community trust building, clinical trial participation, and reliable information dissemination regarding COVID-19 vaccines. Modifying recruitment, outreach, and trial protocols led to majority-minority participants (55%-78%) in each of the three vaccine clinical trials. CCP's input led to cultural tailoring of recruitment materials, changes in recruitment messaging, and supportive services to improve trial accessibility and acceptability (transportation, protocols for cultural competency, and support linkages to care in case of an adverse event). Barriers to clinical trial participation unable to be resolved included childcare, requests for after-hours appointment availability, and mobile locations for trial visits. Conclusion:Using deliberative community engagement can provide critical and timely insight into the community-centered barriers to COVID-19 vaccine trial participation, including addressing social determinants of health, trust, clinical trial literacy, structural barriers, and identifying trusted messenger and reliable sources of information.

8 May 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
Yelba M. Castellon-LopezYelba M. Castellon-Lopez
Yelba M. Castellon-Lopez
AKAlexandra M Klomhaus
Alexandra M Klomhaus
CGCruz Garcia
Cruz Garcia
YCYelba Castellon-Lopez
Yelba Castellon-Lopez
HAHilda Avila
Hilda Avila
LBLuisa Blanco
Luisa Blanco
We developed and tested MivacunaLA/MyshotLA, a community-informed mobile phone intervention, to increase COVID-19 vaccination among Latino parents/caretakers of minors in under-resourced areas of Los Angeles by addressing misinformation and building trust. We recruited Latino parents/caregivers with at least one unvaccinated child in East and South Los Angeles in the summer of 2021 and evaluated MivacunaLA as a randomized controlled trial with a wait-list control group. A difference-in-difference analysis showed Latino parents/caregivers that participated in MivacunaLA (n = 246), in comparison to the control group, were 15 percentage points more likely (p = 0.04) to report vaccination of minors aged 12–17 years, and 12 percentage points more likely (p = 0.03) to report a positive intention to vaccinate minors aged 2–11 years (when COVID-19 vaccines became available). Mobile phone-delivered digital interventions using videos and culturally tailored educational material to promote COVID-19 vaccine confidence can be an effective way to combat misinformation and deliver timely information to marginalized communities. Community-based participatory research approaches are crucial to advance health equity among minority communities, especially immigrant Spanish-speaking underserved communities.

11 March 2020 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
Yelba M. Castellon-LopezYelba M. Castellon-Lopez
Yelba M. Castellon-Lopez
KJKia Skrine Jeffers
Kia Skrine Jeffers
ODO. Kenrik Duru
O. Kenrik Duru
GMGerardo Moreno
Gerardo Moreno
TMTannaz Moin
Tannaz Moin
RHRon D. Hays
Ron D. Hays

30 May 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
MPMichael Panameno
Michael Panameno
LBLuisa Blanco
Luisa Blanco
AHAnn Marie Hernandez
Ann Marie Hernandez
Renato EscobarRenato Escobar
Renato Escobar
BZBrittney Zendejas
Brittney Zendejas
Yelba M. Castellon-LopezYelba M. Castellon-Lopez
Yelba M. Castellon-Lopez
Background: Latinx school-aged children are more than twice as likely to be infected with and die from COVID-19 as non-Latinx White children in Los Angeles. Although COVID-19 vaccination has the potential to mitigate health disparities exacerbated by the pandemic, vaccination uptake among Latinx children remains limited. MiVacunaLA (MVLA) is a mobile-phone-delivered digital intervention that improved vaccination rates in 12- to 17-year-old Latinx children and parental intention to vaccinate 2- to 11-year-old children. Since piloting MVLA, the COVID-19 vaccine became available to children aged 5–11. We sought to understand parental experiences with the MVLA intervention and their attitudes and beliefs about vaccinating their young children to improve vaccination confidence in the Latinx community. Methods: We conducted six virtual focus groups with 47 parents/caregivers of children aged 5–11 who participated in the MVLA intervention. We used standard qualitative content analysis methods and rigid and accelerated data reduction to identify and analyze major themes discussed in the sessions. Results: Each salient theme from our focus groups was mapped to one of the 5Cs constructs. The themes included the parents’ need for more contemplation about vaccinating their children than about vaccinating themselves; the parents’ need for trusted sources of vaccine information; the parents’ motivations to vaccinate their children against COVID-19; parental concern about short- and long-term effects of the vaccine in children; digital technology and videos as useful engagement tools; and age and health stratification as an approach to parental vaccination decision-making. Conclusions: The results of this study clarify the key factors that influence the decision of Latinx parents and caregivers to vaccinate their children against COVID-19. Our findings can inform efforts to increase COVID-19 vaccination rates among children in underserved Latinx communities, especially regarding the use of digital technologies for promoting vaccine confidence.

23 December 2024 in Bladder Cancer
Verified
Journal Article
Open access
Yelba M. Castellon-LopezYelba M. Castellon-Lopez
Yelba M. Castellon-Lopez
PTPatricia Thompson
Patricia Thompson
The United States has seen a decrease in the incidence of bladder cancer and a decline in mortality rates over the past 20 years. However, not all groups have benefited equally from this trend. The American Association of Community Cancer Centers (ACCC) has issued ten strategies to improve cancer care delivery for underserved patient populations. Unfortunately, the evidence supporting the best methods for reducing disparities in different patient groups and care delivery settings remains severely limited. In this short communication, using a personalized narrative woven into a clinical case, we highlight the need for more research on bladder cancer care delivery to ensure that significant investments in precision oncology translate into genuine improvements for all patients diagnosed with bladder cancer.